Clinical Trial Update: A Study to Evaluate RMC-035 in Subjects Undergoing Cardiac Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial update for RMC-035 in subjects undergoing cardiac surgery completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• RMC-035

Snippet

Sponsor: Guard Therapeutics AB | Conditions: Acute Kidney Injury (AKI) | Phase 1 | Status: COMPLETED | Results posted: 2023-12-04